News and Events



LCA 2016 Screening & Care Conference

Imbio will exhibit at the Lung Cancer Alliance's 2nd Annual Lung Cancer Screening & Care Conference in Washington, DC, September 23 to September 24, 2016.

READ MORE

Imbio announces $1.5 million financing

Fund PRM Lung, CT Imaging Biomarker for COPD

Imbio, LLC, a medical imaging software company, has closed on $1.5 million in Series A financing. Existing investor Invenshure, LLC, led the round with additional funding from several angel investors. The proceeds will support the commercialization of Imbio’s proprietary Parametric Response Mapping…

READ MORE

CHEST 2016

Imbio will exhibit at CHEST 2016 in Los Angeles, California, October 22 to October 26, 2016. Visit us at booth #1539.

READ MORE

Imbio and NTT DATA Services Announce Partnership for Lung Analytic Algorithms in the UCA Imaging Platform

NTT DATA Services, formerly Dell Services, today announced its partnership with Imbio, which will provide algorithms for lung analytics. The algorithms are designed to further enhance automated tools to assist radiology in identifying and quantifying disease present in existing and new imaging studi…

READ MORE

RNSA 2016

Imbio will exhibit at Radiological Society of North America's Annual Meeting in Chicago, Illinois, November 27 to December 2, 2016. Booth #TBD.

READ MORE

Imbio and GE Healthcare Collaborate to Enable Lung Density Analysis™ Within GE Health Cloud Ecosystem

Imbio and GE Healthcare to support more personalized CT lung diagnosis with quantifiable clinical insights

MINNEAPOLIS, March 21, 2016 /PRNewswire/ -- Imbio, a leader in fully automated, biomarker-based solutions for quantitative Lung imaging, and GE Healthcare are pleased to announce a collaboration to make Imbio’s Lung Density AnalysisTM, a volumetric imaging solution for Lung CT, one of the first soft…

READ MORE

Imbio obtains exclusive commercialization rights to Heidelberg University Hospital’s Airway Tree Analysis software

MINNEAPOLIS, Minnesota— Imbio, LLC, a diagnostic medical imaging software company, announced today that the company has exclusively licensed technology for evaluation of the lung airway tree developed by researchers at the Heidelberg University Hospital.

Extracting and labeling the bronchial tree…

READ MORE

Imbio Named Finalist for 16th Annual TEKNE Awards

MHTA to honor Minnesota’s top technology companies and individuals at annual awards ceremony

MINNEAPOLIS, Minnesota - The Minnesota High Tech Association (MHTA) has named Imbio as a finalist in the Healthcare – Small & Growing category for the 2015 Tekne Awards, which will be held at the Minneapolis Convention Center on Thursday, Nov. 18. The Tekne Awards honor Minnesota companies and indiv…

READ MORE

IMBIO’S CT LUNG ANALYSIS SOFTWARE RECEIVES 510(k) CLEARANCE FROM FDA

Image Processing Software Quantifies Extent of Lung Tissue Damage in COPD

MINNEAPOLIS, Minnesota—Imbio, LLC, a medical image processing software company, has received FDA 510(k) clearance for their Lung Density Analysis software application, developed in collaboration with medical researchers at the University of Michigan.

COPD (Chronic Obstructive Pulmonary Disease) is…

READ MORE